Description: Critical factors to consider as we age include where we live, who we interact with, how we get the help and support we need when we need it, and how our health care is organized and delivered. Underlying this is how we finance the cost of specialized housing, care and support. Some communities are age-friendly where we can obtain supportive services, others are not. Some people choose to live in senior housing which integrates support services, others choose to live in the community among people of all ages. Some health care systems are well designed to meet the needs of older people, others are not. The cost of living for older adults, considering all of these factors, varies by community. Explore more about the perspective of older adults, how communities have structured to meet their needs, and how society as a whole is becoming aware of and addressing a growing aging population.

Description: Articles on IRS private letter rulings on combination products, IRS treatment of reinsurance under section 845, and IRS waivers for failed contracts under section 7702.

Description: In the modern world, users expect a top-notch user experience on whatever device they are using. Marketing, distribution, and user experience have become the trinity in finding, acquiring, and keeping a user through the end of an application process. Recently, particularly in the post-COVID digital-first world, many insurance companies have transformed their technology teams to build significantly improved user-experiences on their websites and mobile apps. The designs are often limited by the insurance products that the consumer wants to interact with (and how they want to interact). In this session, the presenters will look at how actuaries can design the insurance product simultaneously to the user experience, and let the experience drive product development.

Description: This session from the 1983 SOA Spring Meeting discusses self-insurance and captive insurance companies including the motives for forming captive insurance companies, the captive concept as it applies to credit insurance, bank holding company captive insurers, the financial and non-financial reasons and operational considerations.

Description: As more gene and cell therapies enter the market at increasingly higher price points, they are ushering in a new era of medicine for rare diseases. Unlike most traditional therapies, gene and cell therapies typically have a short or one-time treatment administration and are anticipated to provide long-term clinical benefits. Actuaries must be prepared to assess, manage, and/or mitigate the risks associated with these therapies. This session includes three different perspectives—a regional plan, a stop loss/reinsurance carrier, and a health care consultant.

Description: Retirement planning generally includes a focus on decisions needed at time of retirement, but it often fails to focus on changes during retirement and additional decisions needed as people age. The 2021 SOA Risk Survey and other SOA research documents the lack of focus on future change. It is common for people to lose cognitive ability and generally to become less able to make decisions, manage their finances, their medical care and their lives at high ages.This panel focuses on communication and decision issues. The SOA has recently issued a decision guide on High Age Decisions. The brief identifies four domains for high age decisions: ·Health, health care and staying healthy ·Managing finances ·Housing and transportation ·Support networks The panel will include a discussion of communications and how we change, problems of physical, hearing, sight or cognitive decline and the challenges created and the four domains in the SOA Decision Brief.

Description: With Chapter 20 of the National Association of Insurance Commissioners Valuation Manual (VM-20), the expansion of accelerated underwriting programs and digital distribution, new accounting standards under GAAP long-duration targeted improvements (LDTI) and International Financial Reporting Standard (IFRS) 17, along with a changing interest rate environment, companies may be looking for efficient reinsurance solutions to help address these ever changing and varied challenges. Hear highlights on how reinsurance can be utilized to address the challenges associated with managing new business strain and product competitiveness, earnings and risk management, and capital allocation efficiency. At the conclusion of the session, you will understand the various challenges being faced by direct writing companies today and where reinsurance can be leveraged to improve the returns and competitiveness of product offerings, provide flexibility in capital and tax planning, as well as balancing risk appetite and underwriting profit retention.

Description: 1999 SOA Annual Meeting, San Francisco. Panel of experts provided an overview of expanding insurance and reinsurance markets in Mexico and South America Argentina, Brazil, and Chile and the North American offshore market. They explained the role of reinsurance in these markets, including development, growth, products, solvency/capital requirements, financial reporting, and regulatory aspects.

Description: CEOs of four of the world's leading life reinsurance companies discuss their views on the directions in which the life reinsurance industry is heading. Topics include an explanation of how changes in the world are impacting reinsurers and what actions are being taken by reinsurers to deal with these changes. From the 2002 Record of Society of Actuaries, Volume 28, No. 3. Session 107I of the Boston Annual Meeting.

Description: Trends in mortality have a huge impact on the insurance industry and its products, risks and profitability. Worldwide, life expectancy has increased continuously over the past decades. However, this progress—even without considering the Covid-19 pandemic—has been subject to strong fluctuations. In recent years, an increase in volatility can be observed. Various aspects—medical science, environment, lifestyle—have influenced the trend in the past. How can the life and health industry move forward in these uncertain conditions? In this article, we examine what has gone before and what can be learned from a closer analysis. What are the main drivers of the historical increase in life expectancy? What characterizes the dynamics of the recent past? How can mortality be projected into the future? How good are our methods of prediction and what are the risks? What risk management options are available?